Fred T. Fiedorek - Sep 18, 2023 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Chief Medical Officer
Signature
/s/ Andrew Ashe, Attorney-in-Fact for Fred T. Fiedorek
Stock symbol
VERV
Transactions as of
Sep 18, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 05:05 PM
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Award $0 +180K $0.00 180K Sep 18, 2023 Common Stock 180K $12.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on September 18, 2023. 25% of the shares underlying the option will vest on September 18, 2024, and the remainder are scheduled to vest in equal monthly installments thereafter until September 18, 2027.